TRAF2 and neoplasm: Additionally, CD27 upregulation in this subgroup coincides with that of TRAF2, the canonical adapter of CD27, which was identified as the top hit in a genome-wide CRISPR screen for genes that sensitize tumor cells to T-cell-mediated elimination when CD27 is knocked out58.